Literature DB >> 14696082

Colon cancer screening: where have we come from and where do we go?

Mitchell I Chorost1, Rajiv Datta, Rosemary C Santiago, Byrne Lee, Jyoti Bollman, I Michael Leitman, Bimal C Ghosh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14696082     DOI： 10.1002/jso.20008

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   3.454


× No keyword cloud information.
  3 in total

1.  Colon cancer screening update and management of the malignant polyp.

Authors:  James M Church
Journal:  Clin Colon Rectal Surg       Date:  2005-08

2.  Niclosamide inhibition of STAT3 synergizes with erlotinib in human colon cancer.

Authors:  Lingyi Shi; Hailun Zheng; Wanle Hu; Bin Zhou; Xuanxuan Dai; Yi Zhang; Zhiguo Liu; Xiaoping Wu; Chengguang Zhao; Guang Liang
Journal:  Onco Targets Ther       Date:  2017-03-23       Impact factor: 4.147

3.  Chemopreventive effect of chalcone derivative, L2H17, in colon cancer development.

Authors:  Shanmei Xu; Minxiao Chen; Wenbo Chen; Junguo Hui; Jiansong Ji; Shuping Hu; Jianmin Zhou; Yi Wang; Guang Liang
Journal:  BMC Cancer       Date:  2015-11-09       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.